-
1
-
-
0347694845
-
Meta-analysis: Interferon for the treatment of chronic hepatitis C in dialysis patients
-
Fabrizi F, Dulai G, Dixit V, Bunnapradist S, Martin P. Meta-analysis: Interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther. 2003;18:1071-1081.
-
(2003)
Aliment Pharmacol Ther
, vol.18
, pp. 1071-1081
-
-
Fabrizi, F.1
Dulai, G.2
Dixit, V.3
Bunnapradist, S.4
Martin, P.5
-
2
-
-
0034527627
-
Nosocomial transmission of hepatitis C virus infection in hemodialysis patients: Clinical perspectives
-
Fabrizi F, Martin P, Lunghi G, Ponticelli C. Nosocomial transmission of hepatitis C virus infection in hemodialysis patients: Clinical perspectives. Int J Artif Organs. 2000;23:805-816.
-
(2000)
Int J Artif Organs
, vol.23
, pp. 805-816
-
-
Fabrizi, F.1
Martin, P.2
Lunghi, G.3
Ponticelli, C.4
-
3
-
-
4444232172
-
Hepatitis C infection associated with renal disease and chronic renal failure
-
Poordad FF, Fabrizi F, Martin P. Hepatitis C infection associated with renal disease and chronic renal failure. Semin Liver Dis. 2004;24:69-77.
-
(2004)
Semin Liver Dis
, vol.24
, pp. 69-77
-
-
Poordad, F.F.1
Fabrizi, F.2
Martin, P.3
-
4
-
-
33645023956
-
Investigation of the presence of hepatitis C virus infection in hemodialysis patients and determination of HCV genotypes
-
Bozdayi G, Rota S, Verdi H, Derici U, Sindel S. Investigation of the presence of hepatitis C virus infection in hemodialysis patients and determination of HCV genotypes. Bull Microbiol. 2002;36:247-252.
-
(2002)
Bull Microbiol
, vol.36
, pp. 247-252
-
-
Bozdayi, G.1
Rota, S.2
Verdi, H.3
Derici, U.4
Sindel, S.5
-
5
-
-
0025738233
-
Hepatitis C virus antibodies among risk groups in Turkey
-
Koksal I, Biberoglu K, Biberoglu S, Koc F, Ayma Y, Koksal H. Hepatitis C virus antibodies among risk groups in Turkey. Infection. 1991;19:228-229.
-
(1991)
Infection
, vol.19
, pp. 228-229
-
-
Koksal, I.1
Biberoglu, K.2
Biberoglu, S.3
Koc, F.4
Ayma, Y.5
Koksal, H.6
-
6
-
-
0036295526
-
Hepatitis C infection and the patient with end-stage renal disease
-
Fabrizi F, Poordad F, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002;36:3-10.
-
(2002)
Hepatology
, vol.36
, pp. 3-10
-
-
Fabrizi, F.1
Poordad, F.2
Martin, P.3
-
7
-
-
39749118170
-
-
National Institutes of Health. Management of Hepatitis C: 2002. National Institutes of Health consensus development conference statement. Hepatology. 2002;36(Suppl. 1):3-20.
-
National Institutes of Health. Management of Hepatitis C: 2002. National Institutes of Health consensus development conference statement. Hepatology. 2002;36(Suppl. 1):3-20.
-
-
-
-
8
-
-
39749105502
-
Advances in HCV Treatment: 2006
-
American Association for the Study of Liver Diseases, October 27-31, Boston, Massachusetts. Available from:, Accessed July 2, 2007
-
American Association for the Study of Liver Diseases. Advances in HCV Treatment: 2006. 2006 Annual Meeting, October 27-31, 2006, Boston, Massachusetts. Available from: http://clinicaloptions.com/Hepatitis/ Conference%20Coverage/Boston%202006/Tracks/HCV%20Treatment.aspx. Accessed July 2, 2007.
-
(2006)
2006 Annual Meeting
-
-
-
9
-
-
33645022095
-
Renal transplantation in chronic hepatitis
-
Gane E. Renal transplantation in chronic hepatitis. J Gastroenterol Hepatol. 2004;19:99-102.
-
(2004)
J Gastroenterol Hepatol
, vol.19
, pp. 99-102
-
-
Gane, E.1
-
10
-
-
1442308277
-
Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: Who responds less well?
-
Zeuzem S. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: Who responds less well? Ann Intern Med. 2004;140:370-381.
-
(2004)
Ann Intern Med
, vol.140
, pp. 370-381
-
-
Zeuzem, S.1
-
11
-
-
0035985388
-
Recent advances in the management of hepatitis C in the dialysis population
-
Fabrizi F, Lunghi G, Martin P. Recent advances in the management of hepatitis C in the dialysis population. Int J Artif Organs. 2002;25:503-511.
-
(2002)
Int J Artif Organs
, vol.25
, pp. 503-511
-
-
Fabrizi, F.1
Lunghi, G.2
Martin, P.3
-
12
-
-
0031593545
-
Pharmacokinetics of alpha-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: Clinical implications
-
Rostaing L, Chatelut E, Payen JL, et al. Pharmacokinetics of alpha-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: Clinical implications. J Am Soc Nephrol. 1998;9:2344-2348.
-
(1998)
J Am Soc Nephrol
, vol.9
, pp. 2344-2348
-
-
Rostaing, L.1
Chatelut, E.2
Payen, J.L.3
-
13
-
-
33645034186
-
Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C
-
Kokoglu OF, Ucmak H, Hosoglu S, et al. Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C. J Gastroenterol Hepatol. 2006;21:575-580.
-
(2006)
J Gastroenterol Hepatol
, vol.21
, pp. 575-580
-
-
Kokoglu, O.F.1
Ucmak, H.2
Hosoglu, S.3
-
14
-
-
34748874598
-
The kidney transplant recipient with hepatitis c infection: Pre- and posttransplantation treatment
-
Terrault NA, Adey DB. The kidney transplant recipient with hepatitis c infection: Pre- and posttransplantation treatment. Clin J Am Soc Nephrol. 2007;2:563-575.
-
(2007)
Clin J Am Soc Nephrol
, vol.2
, pp. 563-575
-
-
Terrault, N.A.1
Adey, D.B.2
-
16
-
-
0041317671
-
Pharmacokinetics of peginterferons
-
l, 23-28
-
Zeuzem S, Welsch C, Herrmann E. Pharmacokinetics of peginterferons. Semin Liver Dis. 2003;23 (Suppl. l.):23-28.
-
(2003)
Semin Liver Dis
, vol.23
, Issue.SUPPL.
-
-
Zeuzem, S.1
Welsch, C.2
Herrmann, E.3
-
17
-
-
33748592811
-
Pegylated-interferon alpha 2a treatment for chronic hepatitis C patients on chronic hemodialysis
-
Sporea I, Popescu A, Sirli R, et al. Pegylated-interferon alpha 2a treatment for chronic hepatitis C patients on chronic hemodialysis. World J Gastroenterol. 2006;12:4191-4194.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 4191-4194
-
-
Sporea, I.1
Popescu, A.2
Sirli, R.3
-
18
-
-
33846999883
-
Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection
-
Chan TM, Ho SK, Tang CS, Tse KC, Lam MF, Lai KN, Yung S. Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection. Nephrology. 2007;12:11-17.
-
(2007)
Nephrology
, vol.12
, pp. 11-17
-
-
Chan, T.M.1
Ho, S.K.2
Tang, C.S.3
Tse, K.C.4
Lam, M.F.5
Lai, K.N.6
Yung, S.7
-
19
-
-
3142702669
-
Pegylated interferon-alpha 2b monotherapy for hemodialysis patients with chronic hepatitis C
-
Annicchiarico BE, Siciliano M. Pegylated interferon-alpha 2b monotherapy for hemodialysis patients with chronic hepatitis C. Aliment Pharmacol Ther. 2004;20:123-124.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 123-124
-
-
Annicchiarico, B.E.1
Siciliano, M.2
-
20
-
-
31544438279
-
Randomized trial of pegylated interferon alpha-2b monotherapy in hemodialysis patients with chronic hepatitis C
-
Russo MW, Ghalib R, Sigal S, Joshi V. Randomized trial of pegylated interferon alpha-2b monotherapy in hemodialysis patients with chronic hepatitis C. Nephrol Dial Transplant. 2006;21:437-443.
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 437-443
-
-
Russo, M.W.1
Ghalib, R.2
Sigal, S.3
Joshi, V.4
-
21
-
-
14944368258
-
Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?
-
Potthoff A, Wiegand J, Luth JB, Wedemeyer H, Manns MP, Tillmann HL. Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C? Clin Nephrol. 2005;63:232-235.
-
(2005)
Clin Nephrol
, vol.63
, pp. 232-235
-
-
Potthoff, A.1
Wiegand, J.2
Luth, J.B.3
Wedemeyer, H.4
Manns, M.P.5
Tillmann, H.L.6
-
22
-
-
18944400270
-
Pegylated interferon for the treatment of hepatitis C virus in hemodialysis patients
-
Teta D, Luscher BL, Gonvers JJ, Francioli P, Phan O, Burnier M. Pegylated interferon for the treatment of hepatitis C virus in hemodialysis patients. Nephrol Dial Transplant. 2005;20:991-993.
-
(2005)
Nephrol Dial Transplant
, vol.20
, pp. 991-993
-
-
Teta, D.1
Luscher, B.L.2
Gonvers, J.J.3
Francioli, P.4
Phan, O.5
Burnier, M.6
-
23
-
-
33947274748
-
Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: Results from a large, multicenter audit
-
Covic A, Maftei ID, Mardare NG, et al. Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: Results from a large, multicenter audit. J Nephrol. 2006;19:794-801.
-
(2006)
J Nephrol
, vol.19
, pp. 794-801
-
-
Covic, A.1
Maftei, I.D.2
Mardare, N.G.3
-
25
-
-
0037299204
-
Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype Ib and high virus load
-
Arase Y, Ikeda K, Tsubota A, et al. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype Ib and high virus load. J Gastroenterol. 2003;2:158-163.
-
(2003)
J Gastroenterol
, vol.2
, pp. 158-163
-
-
Arase, Y.1
Ikeda, K.2
Tsubota, A.3
-
26
-
-
9744247626
-
Current treatment for chronic hepatitis C
-
Ferenci P. Current treatment for chronic hepatitis C. Curr Treat Options Gastroenterol. 2004;7:491-499.
-
(2004)
Curr Treat Options Gastroenterol
, vol.7
, pp. 491-499
-
-
Ferenci, P.1
-
27
-
-
0141459375
-
Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: A population-based cohort study
-
Watanabe H, Saito T, Shinzawa H, et al. Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: A population-based cohort study. J Med Virol. 2003;71:56-61.
-
(2003)
J Med Virol
, vol.71
, pp. 56-61
-
-
Watanabe, H.1
Saito, T.2
Shinzawa, H.3
-
28
-
-
0036102602
-
Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population
-
Kondili LA, Chionne P, Costantino A, et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut. 2002;50:693-696.
-
(2002)
Gut
, vol.50
, pp. 693-696
-
-
Kondili, L.A.1
Chionne, P.2
Costantino, A.3
-
29
-
-
0037784059
-
Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance
-
Mazzeo C, Azzaroli F, Giovanelli S, et al. Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. Gut. 2003;52:1030-1034.
-
(2003)
Gut
, vol.52
, pp. 1030-1034
-
-
Mazzeo, C.1
Azzaroli, F.2
Giovanelli, S.3
-
30
-
-
0036829817
-
Use and interpretation of virological tests for hepatitis C
-
Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology. 2002;36:65-73.
-
(2002)
Hepatology
, vol.36
, pp. 65-73
-
-
Pawlotsky, J.M.1
-
31
-
-
0028805250
-
Interferonalpha 2b treatment of chronic hepatitis C in hemodialysis patients
-
Raptopoulou-Gigi M, Spaia S, Garifallos A, et al. Interferonalpha 2b treatment of chronic hepatitis C in hemodialysis patients. Nephrol Dial Transplant. 1995;10:1834-1837.
-
(1995)
Nephrol Dial Transplant
, vol.10
, pp. 1834-1837
-
-
Raptopoulou-Gigi, M.1
Spaia, S.2
Garifallos, A.3
-
32
-
-
0031091154
-
A double-blind controlled trial of recombinant interferon-alpha 2b in hemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels
-
Fernandez JL, Rendo P, del Pino N. A double-blind controlled trial of recombinant interferon-alpha 2b in hemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. J Viral Hepatitis. 1997;4:113-119.
-
(1997)
J Viral Hepatitis
, vol.4
, pp. 113-119
-
-
Fernandez, J.L.1
Rendo, P.2
del Pino, N.3
-
33
-
-
0030661749
-
High rate of hepatitis C virus clearance in hemodialysis patients after interferonalpha therapy
-
Izopet J, Rostaing L, Moussion F, et al. High rate of hepatitis C virus clearance in hemodialysis patients after interferonalpha therapy. J Infect Dis. 1997;176:1614-1617.
-
(1997)
J Infect Dis
, vol.176
, pp. 1614-1617
-
-
Izopet, J.1
Rostaing, L.2
Moussion, F.3
-
34
-
-
0033281416
-
Efficacy and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C virus infection in hemodialysis patients. Pre- and post-renal transplantation assessment
-
Campistol JM, Esforzado N, Martinez J, et al. Efficacy and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C virus infection in hemodialysis patients. Pre- and post-renal transplantation assessment. Nephrol Dial Transplant. 1999;14:2704-2709.
-
(1999)
Nephrol Dial Transplant
, vol.14
, pp. 2704-2709
-
-
Campistol, J.M.1
Esforzado, N.2
Martinez, J.3
|